Want to see TSE:DHB full AI Analyst Report?
DHB Stock Chart & Stats
C$0.10
-C$0.01(-10.00%)
At close: 4:00 PM EDT
C$0.10
-C$0.01(-10.00%)
Day’s Range― - ―
52-Week RangeC$0.09 - C$0.37
Previous CloseN/A
Volume6.06K
Average Volume (3M)26.13K
Market Cap
C$3.13M
Enterprise ValueC$2.98M
Total Cash (Recent Filing)C$2.64M
Total Debt (Recent Filing)C$2.33M
Price to Earnings (P/E)―
Beta1.72
Next Earnings
Oct 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding31,261,782
10 Day Avg. Volume58,945
30 Day Avg. Volume26,134
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.30
Price to Sales (P/S)0.41
P/FCF Ratio-7.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.53Price Target Upside430.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.01
Revenue Forecast (FY)C$14.12M
Bulls Say, Bears Say
Bulls Say
Healthy Gross MarginA ~45.5% gross margin is a durable structural strength in consumer OTC products: it provides intrinsic product-level profitability and room to cover distribution and marketing. If revenues stabilize, high gross margins support a sustainable path to operating profitability over months.
Positive Equity Base & Moderate LeverageA positive equity base (~$2.9M) and moderate leverage (D/E ~0.79) give the company a balance-sheet buffer and some financing flexibility. This reduces immediate insolvency risk and provides runway to execute turnaround initiatives without urgent recapitalization, a durable financial cushion.
OTC Consumer Health Business ModelA focus on OTC health and wellness sold through retail/distribution is structurally resilient: consistent consumer demand, recurring SKU purchases, and established retail channels can deliver steady revenue streams. This business model supports lasting cash generation once scale and distribution are optimized.
Bears Say
Declining Revenue TrajectoryMaterial TTM revenue decline (-14.1%) is a lasting operational concern: shrinking top line limits leverage of fixed costs, pressures margins and marketing ROI, and signals distribution or demand weakness. Absent a change in growth drivers, this trend impairs sustainable profitability and scale.
Negative Operating And Free Cash FlowNegative operating and free cash flow (~-$0.3M TTM) mean the business is not self-funding. Persistent cash burn forces reliance on external financing, limits reinvestment in marketing or inventory, and raises execution risk over several months if cash generation does not turn positive.
Ongoing UnprofitabilityA sustained negative net margin (~-9%) erodes retained earnings and reduces strategic flexibility. Continued losses compress equity, increase refinancing needs, and hinder reinvestment into growth initiatives, making long-term recovery contingent on consistent margin improvement or revenue stabilization.
Delivra Health Brands News
DHB FAQ
What was Delivra Health Brands’s price range in the past 12 months?
Delivra Health Brands lowest stock price was C$0.09 and its highest was C$0.37 in the past 12 months.
What is Delivra Health Brands’s market cap?
Delivra Health Brands’s market cap is C$3.13M.
When is Delivra Health Brands’s upcoming earnings report date?
Delivra Health Brands’s upcoming earnings report date is Oct 23, 2026 which is in 65 days.
How were Delivra Health Brands’s earnings last quarter?
Delivra Health Brands released its earnings results on May 29, 2026. The company reported -C$0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.03.
Is Delivra Health Brands overvalued?
According to Wall Street analysts Delivra Health Brands’s price is currently Undervalued.
Does Delivra Health Brands pay dividends?
Delivra Health Brands does not currently pay dividends.
What is Delivra Health Brands’s EPS estimate?
Delivra Health Brands’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Delivra Health Brands have?
Delivra Health Brands has 31,261,782 shares outstanding.
What happened to Delivra Health Brands’s price movement after its last earnings report?
Delivra Health Brands reported an EPS of -C$0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Delivra Health Brands?
Currently, no hedge funds are holding shares in TSE:DHB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Delivra Health Brands
Based in Vancouver, Canada, Delivra Health Brands Inc., through its various subsidiaries, distributes an assortment of lifestyle and wellness goods to a global clientele of consumers and medical patients within regulated jurisdictions. The firm's product line includes cannabis, liquid sleep supplements, powdered sleep aids, edible gummies, and topical pain relief solutions. These items are available under well-known brand labels like LivRelief, Dream Water, and LivRelief Infused. The company was formerly recognized as Harvest One Cannabis Inc.
DHB Stock 12 Month Forecast
Average Price Target
C$0.53
▲(430.00% Upside)